Literature DB >> 1325641

A region of herpes simplex virus VP16 can substitute for a transforming domain of Epstein-Barr virus nuclear protein 2.

J I Cohen1.   

Abstract

Epstein-Barr virus (EBV) nuclear protein 2 (EBNA-2) is essential for EBV-induced B-cell transformation in vitro. EBNA-2 contains a 14-amino acid domain that directly activates transcription and is required for transformation. To determine whether another transcriptional activator can substitute for this function, a chimeric virus was constructed that contained a portion of the transcriptional activation domain from the herpes simplex virus VP16 protein inserted in place of the 14-amino acid domain of EBNA-2. The chimeric virus was able to transform B cells efficiently and transactivate expression of EBV and B-cell genes. Randomization of the 14-amino acid sequence in the domain markedly reduced its transcriptional activating activity and the transforming efficiency of the recombinant EBV. Mutation of a tryptophan within the 14-amino acid domain of EBNA-2 completely abolished transcriptional activation and B-cell transformation. These experiments indicate that EBNA-2 and VP16 activate transcription by similar mechanisms and that transcriptional activation is required for EBV-induced B-cell transformation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325641      PMCID: PMC49849          DOI: 10.1073/pnas.89.17.8030

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Cellular targets for transformation by the adenovirus E1A proteins.

Authors:  P Whyte; N M Williamson; E Harlow
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

2.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

3.  Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.

Authors:  F Wang; H Kikutani; S F Tsang; T Kishimoto; E Kieff
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.

Authors:  J I Cohen; E Kieff
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Critical structural elements of the VP16 transcriptional activation domain.

Authors:  W D Cress; S J Triezenberg
Journal:  Science       Date:  1991-01-04       Impact factor: 47.728

6.  An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide.

Authors:  P R Winship
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

7.  Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.

Authors:  F Wang; C Gregory; C Sample; M Rowe; D Liebowitz; R Murray; A Rickinson; E Kieff
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

8.  Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

Authors:  F Wang; S F Tsang; M G Kurilla; J I Cohen; E Kieff
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

9.  Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.

Authors:  M Rabson; L Gradoville; L Heston; G Miller
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

10.  An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120.

Authors:  M E Ewen; J W Ludlow; E Marsilio; J A DeCaprio; R C Millikan; S H Cheng; E Paucha; D M Livingston
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

View more
  28 in total

1.  A role of transcriptional activators as antirepressors for the autoinhibitory activity of TATA box binding of transcription factor IID.

Authors:  T Kotani; K Banno; M Ikura; A G Hinnebusch; Y Nakatani; M Kawaichi; T Kokubo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 2.  The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.

Authors:  H J Delecluse; W Hammerschmidt
Journal:  Mol Pathol       Date:  2000-10

3.  Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association.

Authors:  S Harada; R Yalamanchili; E Kieff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.

Authors:  Alexey V Gordadze; Chisaroka W Onunwor; RongSheng Peng; David Poston; Elisabeth Kremmer; Paul D Ling
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

5.  Four EBNA2 domains are important for EBNALP coactivation.

Authors:  Chih-Wen Peng; Bo Zhao; Elliott Kieff
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.

Authors:  E M Fuentes-Pananá; P D Ling
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.

Authors:  L Wang; S R Grossman; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

8.  Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.

Authors:  Bo Zhao; James Zou; Hongfang Wang; Eric Johannsen; Chih-wen Peng; John Quackenbush; Jessica C Mar; Cynthia Casson Morton; Matthew L Freedman; Stephen C Blacklow; Jon C Aster; Bradley E Bernstein; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

9.  The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.

Authors:  X Tong; R Yalamanchili; S Harada; E Kieff
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation.

Authors:  Chih-Wen Peng; Yong Xue; Bo Zhao; Eric Johannsen; Elliott Kieff; Shizuko Harada
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.